Efficacy and safety of long-acting pasireotide in japanese patients with acromegaly or pituitary gigantism: Results from a multicenter, open-label, randomized, phase 2 study

behalf of SOM230C1202 study group

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of long-acting pasireotide in japanese patients with acromegaly or pituitary gigantism: Results from a multicenter, open-label, randomized, phase 2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences